Goldman Sachs has never issued a stock split, but its soaring stock price has the Dow off balance.

A looming NASA deadline and anxious investors put Elon Musk between a space rock and a hard place.

Eli Lilly (NYSE: LLY) received approval for Zepbound, a weight-management medicine, in November 2023. Since then, Zepbound has performed extremely well and become the best-selling anti-obesity drug, ...

Falling below $125 per share today, Space Exploration Technologies (NASDAQ: SPCX) stock is officially a broken IPO now -- trading $10 below the point at which it priced its IPO last month. Investors ...

Whether President Donald Trump and those around him are corruptly enriching themselves during Trump’s second term is a matter ...

Learn in our Grok AI review if it's the right AI assistant for your workflow. Compare its features, pricing, coding ...

TORONTO – Canada’s main stock index edged lower on weakness in the technology sector as falling AI stocks dragged U.S.

Palm Garden AI is developing a hardware-agnostic software layer, including Coherence Guard, for human-robot interaction and ...

The US president's posts often move markets, and even a tiny speed advantage can lead to big gains on trades for investors ...

An immune system has one design flaw that no amount of engineering ever fully solves: the same mechanisms that let it ...